PennyMac Mortgage Investment Trust — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PennyMac Mortgage Investment Trust filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $155.04M | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $130.76M | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $96.40M | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $106.62M | Feb 21, 2020 |
| FY2019 | Dec 31, 2018 | $83.90M | Feb 21, 2020 |
| FY2019 | Sep 30, 2018 | $108.50M | Feb 21, 2020 |
| FY2019 | Jun 30, 2018 | $82.99M | Feb 21, 2020 |
| FY2019 | Mar 31, 2018 | $75.67M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $93.70M | Feb 26, 2019 |
| FY2018 | Sep 30, 2017 | $75.80M | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.87M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $160.98M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $199.65M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($73.29M) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $56.85M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $52.37M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $58.60M | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $70.00M | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $44.23M | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $53.53M | Feb 21, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.21B) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($2.70B) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.34B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.78B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | ($2.82B) | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $671.66M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | ($2.99B) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | ($573.75M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $223.13M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | ($621.54M) | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.35B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $14.41B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $13.11B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $13.92B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $13.77B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $11.49B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $11.77B | Feb 25, 2022 |
| FY2019 | Sep 30, 2019 | $10.74B | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $9.47B | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $7.56B | Feb 21, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.46B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $12.47B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $11.16B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $11.96B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $11.41B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $9.20B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $9.32B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $8.52B | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $7.52B | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $5.83B | Feb 21, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.89B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.94B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.96B | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $1.96B | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $2.37B | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $2.30B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $2.45B | Feb 24, 2023 |
| FY2019 | Sep 30, 2019 | $2.22B | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $1.94B | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $1.73B | Feb 21, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($582.83M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($528.92M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | ($508.70M) | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | ($526.82M) | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | ($256.67M) | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | ($100.73M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $22.32M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($19.72M) | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | ($46.67M) | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | ($26.72M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $59.85M | Feb 26, 2019 |
| FY2018 | Dec 31, 2017 | $77.65M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $34.48M | Feb 26, 2019 |
| FY2011 | Dec 31, 2011 | $14.59M | Mar 9, 2012 |
| FY2011 | Dec 31, 2010 | $45.45M | Mar 9, 2012 |
| FY2011 | Dec 31, 2009 | $54.0K | Mar 9, 2012 |
| FY2011 | Aug 4, 2009 | $1.0K | Mar 9, 2012 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2029 | $1.62B | Feb 22, 2024 |
| FY2023 | Dec 31, 2028 | $423.50M | Feb 22, 2024 |
| FY2023 | Dec 31, 2027 | $305.00M | Feb 22, 2024 |
| FY2023 | Dec 31, 2026 | $695.00M | Feb 22, 2024 |
| FY2023 | Dec 31, 2025 | $1.09B | Feb 22, 2024 |
| FY2023 | Dec 31, 2024 | $1.01B | Feb 22, 2024 |
| FY2023 | Dec 31, 2023 | $5.15B | Feb 22, 2024 |
| FY2022 | Dec 31, 2022 | $5.07B | Feb 24, 2023 |
| FY2021 | Dec 31, 2021 | $4.49B | Feb 25, 2022 |
| FY2019 | Dec 31, 2019 | $2.16B | Feb 21, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 21, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 87.02M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 86.86M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 86.62M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 88.89M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 94.90M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 97.86M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 100.18M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 60.95M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 61.33M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 66.70M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.37M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $139.30M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $140.62M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $173.55M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $183.97M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $151.58M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $141.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $115.60M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $126.14M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $131.56M | Feb 26, 2019 |